No Data
Genscript Biotech's Associate Logs $334 Million in Carvykti Drug Sales in Q4
GENSCRIPT BIO is currently up over 6%. CARVYKTI's fourth quarter trade sales net amount to approximately 0.334 billion dollars.
GENSCRIPT BIO (01548) rose over 6% during the day; as of the time of writing, the stock price has increased by 5.86%, currently reported at 10.84 Hong Kong dollars, with a transaction volume of 92.7179 million Hong Kong dollars.
Hong Kong Stock Market Announcement | China Pacific Insurance expects the net income attributable to shareholders for the year 2024 to be approximately 42.2 billion to 46.3 billion yuan, representing an increase of about 55% to 70% year-on-year.
CMOC Group Limited (03993) issued a profit warning, expecting an annual net income of 12.8 billion yuan to 14.2 billion yuan, an increase of 55.15%-72.12% year-on-year; COFCO PACKAGING (00906): Huari will exercise its rights under the company's regulations to privatize the company.
GenScript's 2025 JPM Global Forum Concludes Successfully in San Francisco
Even After Rising 10% This Past Week, Genscript Biotech (HKG:1548) Shareholders Are Still Down 67% Over the Past Three Years
Is the rebound trend of Hong Kong stocks established? The Hang Seng Index temporarily returned to 20,000 points, and the performance of Cryptos stocks is eye-catching.
① How do Institutions view the phenomenon of the Hong Kong stock market warming up? ② What news primarily drives the rising trend of pharmaceutical stocks?
Genscript Biotech Corporation's (HKG:1548) P/S Is Still On The Mark Following 29% Share Price Bounce
